ARTICLE | Clinical News
Carboxypeptidase G2 regulatory update
February 24, 2003 8:00 AM UTC
The EMEA granted Orphan Medicinal Product designation to Carboxypeptidase G2 for use as an adjunctive treatment in patients at risk of methotrexate toxicity. ...